Insider Trading History of Champsi Farah

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Champsi Farah since 2009. The trader's CIK number is 1198321. At the time of the last reporting, Champsi Farah was the 10% Owner of Kite Pharma, Inc.. (stock ticker symbol KITE). Also see all insider trading activities at Kite Pharma, Inc..

Note that in the past CHAMPSI FARAH also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Corcept Therapeutics Inc (CORT) by Champsi Farah

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2009 CORT 349,651 $482,518 0 $0 0 $0

Yearly summary of insider trading at Immune Design Corp. (IMDZ) by Champsi Farah

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 IMDZ 299,559 $3,594,708 0 $0 0 $0

Yearly summary of insider trading at Sunesis Pharmaceuticals Inc (SNSS) by Champsi Farah

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 SNSS 11,912,224 $3,275,861 0 $0 0 $0
2009 SNSS 0 $0 2,232,464 $4,485,020 0 $0

Yearly summary of insider trading at Kite Pharma, Inc. (KITE) by Champsi Farah

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 KITE 0 $0 278,907 $23,203,054 0 $0
2015 KITE 0 $0 664,102 $41,538,251 0 $0

Yearly summary of insider trading at Chimerix Inc (CMRX) by Champsi Farah

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 CMRX 0 $0 447,499 $6,940,709 0 $0

Yearly summary of insider trading at Scynexis Inc (SCYX) by Champsi Farah

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 SCYX 900,000 $9,000,000 0 $0 0 $0

Yearly summary of insider trading at Zs Pharma, Inc. (ZSPH) by Champsi Farah

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 ZSPH 200,000 $3,600,000 0 $0 0 $0


Insider trading activities at 7 companies by Champsi Farah:

1. Corcept Therapeutics Inc (CORT)

2. Immune Design Corp. (IMDZ)

3. Sunesis Pharmaceuticals Inc (SNSS)

4. Kite Pharma, Inc. (KITE)

5. Chimerix Inc (CMRX)

6. Scynexis Inc (SCYX)

7. Zs Pharma, Inc. (ZSPH)

Table 1. Insider trading of Corcept Therapeutics Inc (CORT) by Champsi Farah

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2009-10-16 CORT Buy 349,651 1.38 482,518

Table 2. Insider trading of Immune Design Corp. (IMDZ) by Champsi Farah

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-07-29 IMDZ Buy 299,559 12.00 3,594,708

Table 3. Insider trading of Sunesis Pharmaceuticals Inc (SNSS) by Champsi Farah

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-06-30 SNSS Buy 11,912,224 .28 3,275,861
2009-12-14 SNSS Sale 2,232,464 2.01 4,485,020

Table 4. Insider trading of Kite Pharma, Inc. (KITE) by Champsi Farah

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-06-14 KITE Sale 15,000 90.40 1,356,000
2017-06-16 KITE Sale 5,450 88.11 480,199
2017-04-27 KITE Sale 16,551 82.77 1,369,926
2017-04-28 KITE Sale 2,617 82.59 216,138
2017-04-26 KITE Sale 51,312 82.89 4,253,251
2017-04-24 KITE Sale 25,818 82.34 2,125,854
2017-04-25 KITE Sale 46,783 82.92 3,879,480
2017-04-17 KITE Sale 43,101 82.77 3,567,469
2017-04-13 KITE Sale 72,275 82.39 5,954,737
2015-06-30 KITE Sale 664,102 62.55 41,538,251

Table 5. Insider trading of Chimerix Inc (CMRX) by Champsi Farah

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-10-23 CMRX Sale 447,499 15.51 6,940,709

Table 6. Insider trading of Scynexis Inc (SCYX) by Champsi Farah

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-05-07 SCYX Buy 900,000 10.00 9,000,000

Table 7. Insider trading of Zs Pharma, Inc. (ZSPH) by Champsi Farah

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-06-23 ZSPH Buy 200,000 18.00 3,600,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Champsi Farah (10% Owner of Kite Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.